Compare GPMT & ORMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GPMT | ORMP |
|---|---|---|
| Founded | 2015 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 119.9M | 134.1M |
| IPO Year | 2017 | N/A |
| Metric | GPMT | ORMP |
|---|---|---|
| Price | $2.14 | $3.39 |
| Analyst Decision | Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $3.00 | N/A |
| AVG Volume (30 Days) | 190.7K | ★ 325.6K |
| Earning Date | 02-11-2026 | 11-13-2025 |
| Dividend Yield | ★ 9.66% | 7.72% |
| EPS Growth | N/A | ★ 838.25 |
| EPS | N/A | ★ 1.03 |
| Revenue | N/A | ★ $2,000,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $20.12 | N/A |
| P/E Ratio | ★ N/A | $3.15 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.61 | $1.82 |
| 52 Week High | $3.19 | $3.71 |
| Indicator | GPMT | ORMP |
|---|---|---|
| Relative Strength Index (RSI) | 36.82 | 48.41 |
| Support Level | $2.06 | $3.24 |
| Resistance Level | $2.25 | $3.52 |
| Average True Range (ATR) | 0.09 | 0.16 |
| MACD | -0.01 | -0.05 |
| Stochastic Oscillator | 4.55 | 9.76 |
Granite Point Mortgage Trust Inc focuses on directly originating, investing in, and managing senior floating rate commercial mortgage loans and other debt and debt-like commercial real estate investments. The company constructs its investment portfolio on a loan-by-loan basis, emphasizing rigorous credit underwriting, selectivity, and diversification, and assesses each investment from a fundamental value perspective relative to other opportunities available in the market. It typically provides intermediate-term bridge or transitional financing for a variety of purposes, including acquisitions, recapitalizations, refinancing, and a range of business plans, including lease-up, renovation, repositioning and repurposing of the property.
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its product pipeline includes ORMD-0801, ORMD-0801, and ORMD 0901.